Request Sample
Request Methodology
Description
Neuronavigation Systems Market size was valued at USD 2,628.1 million in 2021, growing at a CAGR of 7.9% during the forecast period 2022 to 2028. neuronavigation systems market are innovative techniques that are developed for image-guided neurosurgery to aid in the accurate resection of brain tumors. Neuronavigation provides intraoperative orientation to the surgeons and helps in planning a precise surgical approach to the targeted lesion. The sensitive areas of the brain during surgery can be avoided by incorporating the functional data provided by functional MRI and magnetoencephalography (MEG) with neuronavigation. The basic principles of navigated surgery is to see the tip of a pointer in an image space. There must be a relationship between the device space and the image space that has to be established. Thus these systems help surgeons in constructing an accurate approach towards the targeted lesion by providing a proper outline of the surrounding neurovascular structures. The global market provides a detailed overview and which can be segmented by type, application, end-user, and region. By type, the market has been segmented into the optical system and electromagnetic system. By type, the optical system segment is expected to gain a significant growth rate over the forecasted period due to increasing demand for optical system devices for neurological problems. Furthermore, continuous development in the optical system will surely enhance the demand in the healthcare sector. By application, the neuronavigation systems market has been segmented into neurosurgery, spinal surgery, maxillofacial surgery, and ENT surgery. By application, the ENT surgery segment held the largest revenue share of the neuronavigation systems market in past years and is expected to have the fastest growth rate over the forecasted period increasing neurological problems globally. Based on the end user, the segment has been segregated into hospitals, neurology centers, and others. The neurology centers segment is expected to lead the end-user segments owing to rising neurological disorders worldwide, which in turn requires neurological centers from a mass patient population. By region, North America holds the largest market share of the neuronavigation systems market and is expected to dominate the neuronavigation systems market due to the rise in the prevalence of neurological disorders and demand for technologically advanced neurological systems. Furthermore, government funding in this region for the improvement and development of surgical navigation systems and the increasing adoption of minimally invasive surgery is propelling the growth of the neuronavigation systems market in the region.
Key Development:
In Sept 2022, ClearPoint Neuro, Inc. a global therapy-enabling platform company providing navigation and delivery to the brain, announced that it has obtained 510(k) clearance for version 2.1 of the ClearPoint Neuro Navigation software.
